房间隔缺损介入治疗现状与未来(精)

[19] Kru m sdorf U,O ster mayer S,B illinger K,et al.I ncidence and clinical course of

thr ombus f or mati on on atrial sep tal defect and patient f ora men ovale cl osure de2 vices in1000consecutive patients[J].J Am Coll Cardi ol,2004,43:3022309.

[20] Knirsch W,Dodge2Khata m iA,Bal m er C,et al.Aortic sinus2left atrial fistula af2

ter interventi onal cl osure of atrial sep tal defect[J].Catheter Cardi ovasc I nterv, 2005,66:10213.

[21] Am in Z,H ijazi Z M,Bass JL,et al.Er osi on of Amp latzer sep tal occluder device

after cl osure of secundu m atrial sep tal defects:revie w of registry of co mp lica2 ti ons and reco mmendati ons t o m ini m ize future risk[J].Catheter Cardi ovasc I n2 terv,2004,63:4962502.

[22] Suda K,Raboiss on MJ,Piette E,et al.Reversible atri oventricular bl ock ass oci2

ated with cl osure of atrial sep tal defects using the Amp latzer device[J].J Am Coll Cardi ol,2004,43:167721682.

[23] Sch werz mann M,Nedeltchev K,M eier B.Patent f ora men ovale cl osure:a ne w

therapy f or m igraine[J].Catheter Cardi ovasc I nterv,2007,69:2772284. [24] Josep RC,S ophie M,A lierM,et al.I ncidence,ti m ing,and p redictive fact ors of

ne w2onset m igraine headache attact after transscatheter cl osure of atrial sep tal defect or patent f ora men ovale[J].Am J Cardi ol,2008,101:6882692.

[25] Kedhi E,Ver meersch TP.The influence of the percutaneous cl osure of atrial sep tal defect on the occurrence of m igraine[J].Eur Heart J,2005,26:27462 2747. [26] R iesMW,Ka mpmann C,Rupp recht HJ,et al.N ickel release after i m p lantati on

of the Amp latzer occluder[J].Am Heart J,2003,145:7372741.

[27] W ert m an B,AzarbalB,R iedlM,et al.Adverse events ass ociated with nickel al2

lergy in patients underg oing percutaneous atrial sep tal defect or patent f ora men ovale cl osure[J].J Am Coll Cardi ol,2006,47:122621227.

收稿日期:2008205212 (本文编辑:郭 宪

室间隔缺损介入治疗现状及展望 谢学刚 张玉顺 和旭梅 综述

(西安交通大学医学院第一医院心血管科, 陕西 西安 710061 Curren t St a tus and Prospect of Tran sca theter I n terven ti on of Ven tr i cul ar Sept a l D efect X I E Xue2gang, ZHANG Yu2shun, HE Xu2mei

(D epart m ent of Cardiology,The First Hospital of X i’an J iaotong U niversity, X i’an 710061, China

文章编号:100423934(20080320346204 中图分类号:R541.1;R541.1+6 文献标识码:A

摘要: 室间隔缺损是最常见的先天性心内畸形之一,既往外科修补是唯一治疗方法,近年经导管介入治疗室间隔缺损发展迅速,现从适应证、禁忌证、封堵器的选择、治疗效果及如何减少并发症等角度,提出应根据左室造影形态结合超声检查选择封堵器,对患者实施个体化的介入封堵治疗,说明室间隔介入封堵治疗安全有效,可作为具有适应证患者的首选治疗方法。

关键词: 室间隔缺损;介入治疗

Abstract: Ventricular sep tal defect is one of the most common congenital heart malf or mati on.The surgery repair was an unique treat2 ment,but now transcatheter interventi on devel op rap idly.Fr om s ome as pects such as indicati on,contraindicati on,choose of occluder devices, treat m ent outcome,and how t o reduce comp licati ons,we conclude that selecti on of occluder devices must base on left ventricul ography mor2 phous and echocardi ography.Transcatheter cl osure therapy of ventricular sep tal defects is safe and effective.It could be the first choice for